Miro Sciences LtdASX: MSX

Quarterly Activities/Appendix 4C Cash Flow Report

· Issued by Miro Sciences Ltd via ASX

Filed with ASX ·

ASX:NSB ASX Announcement 27 October 2026 Quarterly Activities Report for the Period Ended 30 September 2026 Highlights • Regulatory Engagement (US FDA Pre-IND Meeting): United States Food and Drug Administration (FDA) held a Pre-Investigational New Drug (Pre-IND) meeting to review NSB’s planned...

View Attachment

6ix is reading this filing.

Miro Sciences Ltd on 6ix